D.A. Davidson & Co’s AngioDynamics ANGO Stock Holding History

D.A. Davidson & Co’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-136,333	Closed	-$1.75M	–	1569
2025 Q4	$1.75M	Buy	+136,333	New	+$1.68M	0.01%	708

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

D.A. Davidson & Co's ANGO Position: Q1 2026 in Review

D.A. Davidson & Co sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 136,333 shares — an estimated $1.75M sold.

D.A. Davidson & Co first reported a position in ANGO in Q4 2025 and held it in 1 quarter. The position peaked at $1.75M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

D.A. Davidson & Co reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
D.A. Davidson & Co sold 136,333 AngioDynamics shares in Q1 2026, an estimated $1.75M.
D.A. Davidson & Co first reported a position in AngioDynamics in Q4 2025 and held it in 1 quarter.
D.A. Davidson & Co's AngioDynamics position peaked at $1.75M in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.